Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial.

Makoto Nishio; Fabrice Barlesi; Howard West; Simon Ball; Rodolfo Bordoni; Manuel Cobo; Pascale Dubray Longeras; Jerome Goldschmidt; Silvia Novello; Francisco Orlandi; Rachel E Sanborn; Zsuzsanna Szalai; Grigoriy Ursol; Diana Mendus; Lijia Wang; Xiaohui Wen; Mark McCleland; Tien Hoang; See Phan; Mark A Socinski

Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial.

Makoto Nishio
, Fabrice Barlesi
, Howard West
, Simon Ball
, Rodolfo Bordoni
, Manuel Cobo
, Pascale Dubray Longeras
, Jerome Goldschmidt
, Silvia Novello
, Francisco Orlandi
, Rachel E Sanborn
, Zsuzsanna Szalai
, Grigoriy Ursol
, Diana Mendus
, Lijia Wang
, Xiaohui Wen
, Mark McCleland
, Tien Hoang
, See Phan
, Mark A Socinski

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Thoracic Oncology
State	Published - Jan 1 2020

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Cite this

Nishio, M., Barlesi, F., West, H., Ball, S., Bordoni, R., Cobo, M., Longeras, P. D., Goldschmidt, J., Novello, S., Orlandi, F., Sanborn, R. E., Szalai, Z., Ursol, G., Mendus, D., Wang, L., Wen, X., McCleland, M., Hoang, T., Phan, S., & Socinski, M. A. (2020). Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial. Journal of Thoracic Oncology.

Nishio, M, Barlesi, F, West, H, Ball, S, Bordoni, R, Cobo, M, Longeras, PD, Goldschmidt, J, Novello, S, Orlandi, F, Sanborn, RE, Szalai, Z, Ursol, G, Mendus, D, Wang, L, Wen, X, McCleland, M, Hoang, T, Phan, S & Socinski, MA 2020, 'Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial.', Journal of Thoracic Oncology.

@article{2d91c2a1189945d1b0d22772bc19a2a7,

title = "Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial.",

author = "Makoto Nishio and Fabrice Barlesi and Howard West and Simon Ball and Rodolfo Bordoni and Manuel Cobo and Longeras, \{Pascale Dubray\} and Jerome Goldschmidt and Silvia Novello and Francisco Orlandi and Sanborn, \{Rachel E\} and Zsuzsanna Szalai and Grigoriy Ursol and Diana Mendus and Lijia Wang and Xiaohui Wen and Mark McCleland and Tien Hoang and See Phan and Socinski, \{Mark A\}",

note = "INTRODUCTION: We report final results from the Phase III IMpower132 study evaluating atezolizumab plus carboplatin or cisplatin and pemetrexed (APP) in patients with non-squamous non-small cell lung cancer (NSCLC).",

year = "2020",

month = jan,

day = "1",

language = "American English",

journal = "Journal of Thoracic Oncology",

}

TY - JOUR

T1 - Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial.

AU - Nishio, Makoto

AU - Barlesi, Fabrice

AU - West, Howard

AU - Ball, Simon

AU - Bordoni, Rodolfo

AU - Cobo, Manuel

AU - Longeras, Pascale Dubray

AU - Goldschmidt, Jerome

AU - Novello, Silvia

AU - Orlandi, Francisco

AU - Sanborn, Rachel E

AU - Szalai, Zsuzsanna

AU - Ursol, Grigoriy

AU - Mendus, Diana

AU - Wang, Lijia

AU - Wen, Xiaohui

AU - McCleland, Mark

AU - Hoang, Tien

AU - Phan, See

AU - Socinski, Mark A

N1 - INTRODUCTION: We report final results from the Phase III IMpower132 study evaluating atezolizumab plus carboplatin or cisplatin and pemetrexed (APP) in patients with non-squamous non-small cell lung cancer (NSCLC).

PY - 2020/1/1

Y1 - 2020/1/1

UR - https://digitalcommons.psjhealth.org/publications/4237/

M3 - Article

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

ER -

Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial.

Disciplines

Other files and links

Cite this